Alimera Sciences Inc (NAS:ALIM)
$ 5.54 -0.01 (-0.18%) Market Cap: 301.29 Mil Enterprise Value: 360.44 Mil PE Ratio: 0 PB Ratio: 7.49 GF Score: 41/100

Q2 2020 Alimera Sciences Inc Earnings Call Transcript

Jul 30, 2020 / 01:00PM GMT
Release Date Price: $6 (-0.97%)
Operator

Ladies and gentlemen, thank you for standing by. Good morning and welcome to the Alimera Sciences Second Quarter 2020 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. (Operator Instructions) I would now like to turn the call over to Scott Gordon, President of CORE IR, the company's Investor Relations firm. Please go ahead.

Scott Gordon;CORE IR;President

Thank you, Stanford, and good morning everyone. Thank you for participating in today's conference call. Joining me from Alimera's leadership team are Rick Eiswirth, President and Chief Executive Officer and Phil Jones, Chief Financial Officer. During this call, management will be making forward-looking statements, including statements that address Alimera's expectations for future performance or operational results.

Forward-looking statements involve risks and other factors that may cause actual results to differ materially from those statements. For more information about these risks, please refer to the risk

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot